LEGN Projected Dividend Yield
ADS (Sponsored)/Legend Biotech Corp ( NASDAQ : LEGN )Legend Biotech Corporation is a clinical-stage biopharmaceutical company. Co. is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). 20 YEAR PERFORMANCE RESULTS |
LEGN Dividend History Detail LEGN Dividend News LEGN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |